Showing results (1211-1220 of 1,227) with videos related to
Sort By:
Pageof 123
Oncotarget|April 1, 2015
WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesisLi Qin, Yan-Tao Yin, Fang-Jing Zheng, et al.Journal of Neuro-Oncology|September 30, 2025
Sacituzumab govitecan and stereotactic radiosurgery in the management of HER2 negative breast cancer brain metastases: a multi-institutional reportVaseem M Khatri, Mariella A Mestres-Villanueva, Sierra Daniel, et al.Nature Medicine|May 24, 2011
Lrp5 functions in bone to regulate bone massYajun Cui, Paul J Niziolek, Bryan T MacDonald, et al.Cancer Research|October 22, 2009
Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal modelsChao-Nan Qian, Kyle A Furge, Jared Knol, et al.Cell|March 24, 2018
Impairment of an Endothelial NAD<sup>+</sup>-H<sub>2</sub>S Signaling Network Is a Reversible Cause of Vascular AgingAbhirup Das, George X Huang, Michael S Bonkowski, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2018
ILDR2 Is a Novel B7-like Protein That Negatively Regulates T Cell ResponsesIris Hecht, Amir Toporik, Joseph R Podojil, et al.Journal of the American College of Cardiology|July 5, 2005
Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trialsStefan H Ostermayer, Mark Reisman, Paul H Kramer, et al.NPJ Breast Cancer|November 21, 2024
Multi-institutional report of trastuzumab deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastasesVaseem M Khatri, Mariella A Mestres-Villanueva, Sreenija Yarlagadda, et al.Brain, Behavior, and Immunity|June 1, 2024
Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancerL D Otto-Dobos, C V Grant, A A Lahoud, et al.The Journal of Clinical Investigation|April 30, 2024
Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programsDong Han, Maryam Labaf, Yawei Zhao, et al.Pageof 123